Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia

Pediatric Research

Volumn 52, Issue 1, 2002, Pages 91-94

  Assmann, Birgit ^a,c   Köhler, Martin ^a,d   Hoffmann, Georg F ^c   Heales, Simon ^b   Surtees, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d Neurologisches Rehabilitationszentrum für Kinder und Jugendliche   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ACETAZOLAMIDE; BACLOFEN; CARBIDOPA; DIAZEPAM; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; PHENOBARBITAL; PHENYTOIN; SEROTONIN; TRIHEXYPHENIDYL;

ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID EXAMINATION; CHILD; CHILDHOOD DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE METABOLISM; DYSTONIA; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; METABOLITE; MULTIPLE REGRESSION; PRIORITY JOURNAL; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM;

EID: 0036081162     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200207000-00017     Document Type: Article

References (27)

1. Infantile parkinsonism-dystonia: Tyrosine hydroxylase deficiency
2. Dopa-responsive dystonia: A clinical and molecular genetic study
3. Aromatic L-amino acid decarboxylase deficiency: Clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis
4. Abnormalities of biogenic amine metabolism
5. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene
6. Interacting neurotransmitter systems: A non-experimental approach to the 5HIAA-HVA correlation in human CSF
7. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population
8. Topography of the monoamine neuron systems in the human brain as revealed in fetuses
9. The serotonin-producing neurons of the midbrain median and dorsal raphe nuclei
10. Distribution of serotonin-immunoreactivity in the central nervous system of the rat: Cell bodies and terminals
11. The primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis
12. Serotonergic neuronal systems: What their anatomic organization tells us about function
13. Neurotransmitters in CSF of idiopathic adult-onset dystonia: Reduced 5-HIAA levels as evidence of impaired serotonergic metabolism
14. The behavioral effects of NMDA antagonists in serotonin depleted rats
15. Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat
16. The novel selective and silent 5-HTIA receptor antagonist (+)-WAY-100135 aggravates dystonic movements in a mutant hamster model
17. Serotonin syndrome complicating migraine pharmacotherapy
18. Movement disorders associated with the serotonin selective reuptake inhibitors
19. Selective serotonin-reuptake inhibitor-induced movement disorders
20. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain
21. Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid
22. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid
23. Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies
24. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF)
25. Biochemical hallmarks of tyrosine hydroxylase deficiency
26. Disorders of movement and system degenerations
27. Anatomy of the serotonergic system